{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:09:07Z","timestamp":1787792947728,"version":"build-2784847793"},"reference-count":32,"publisher":"Baishideng Publishing Group Inc.","issue":"39","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2015]]},"DOI":"10.3748\/wjg.v21.i39.11112","type":"journal-article","created":{"date-parts":[[2015,10,22]],"date-time":"2015-10-22T16:24:53Z","timestamp":1445531093000},"page":"11112","source":"Crossref","is-referenced-by-count":21,"title":["Active vaccination to prevent<i>de novo<\/i>hepatitis B virus infection in liver transplantation"],"prefix":"10.3748","volume":"21","author":[{"given":"Chih-Che","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Theilmann L, Arnold J, T&ouml;x U, Datsis K, Otto G, Hofmann W, K&ouml;ck J, Schlicht HJ. Liver transplantation and de novo hepatitis B infection. Lancet 1994;343:677-678.","DOI":"10.1016\/S0140-6736(94)92677-8"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Dickson RC, Everhart JE, Lake JR, Wei Y, Seaberg EC, Wiesner RH, Zetterman RK, Pruett TL, Ishitani MB, Hoofnagle JH. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Gastroenterology 1997;113:1668-1674.","DOI":"10.1053\/gast.1997.v113.pm9352871"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Prieto M, G&oacute;mez MD, Berenguer M, C&oacute;rdoba J, Ray&oacute;n JM, Pastor M, Garc&iacute;a-Herola A, Nicol&aacute;s D, Carrasco D, Orbis JF. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population. Liver Transpl 2001;7:51-58.","DOI":"10.1053\/jlts.2001.20786"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Roque-Afonso AM, Feray C, Samuel D, Simoneau D, Roche B, Emile JF, Gigou M, Shouval D, Dussaix E. Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors. Gut 2002;50:95-99.","DOI":"10.1136\/gut.50.1.95"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Douglas DD, Rakela J, Wright TL, Krom RA, Wiesner RH. The clinical course of transplantation-associated de novo hepatitis B infection in the liver transplant recipient. Liver Transpl Surg 1997;3:105-111.","DOI":"10.1002\/lt.500030202"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Michalak TI, Pasquinelli C, Guilhot S, Chisari FV. Hepatitis B virus persistence after recovery from acute viral hepatitis. J Clin Invest 1994;94:907.","DOI":"10.1172\/JCI116950C1"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1053\/jlts.2003.50157"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Sung JL. Hepatitis B virus infection and its sequelae in Taiwan. Gastroenterol Jpn 1984;19:363-366.","DOI":"10.1007\/BF02779126"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1053\/jlts.2003.50115"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Cholongitas E, Papatheodoridis GV, Burroughs AK. Liver grafts from anti-hepatitis B core positive donors: a systematic review. J Hepatol 2010;52:272-279.","DOI":"10.1016\/j.jhep.2009.11.009"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0012.2011.01409.x"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3182845f97"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Soejima Y, Ikegami T, Taketomi A, Yoshizumi T, Uchiyama H, Harada N, Yamashita Y, Maehara Y. Hepatitis B vaccination after living donor liver transplantation. Liver Int 2007;27:977-982.","DOI":"10.1111\/j.1478-3231.2007.01521.x"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Manzarbeitia C, Reich DJ, Ortiz JA, Rothstein KD, Araya VR, Munoz SJ. Safe use of livers from donors with positive hepatitis B core antibody. Liver Transpl 2002;8:556-561.","DOI":"10.1053\/jlts.2002.33451"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Kwon CH, Suh KS, Yi NJ, Chang SH, Cho YB, Cho JY, Lee HJ, Seo JK, Lee KU. Long-term protection against hepatitis B in pediatric liver recipients can be achieved effectively with vaccination after transplantation. Pediatr Transplant 2006;10:479-486.","DOI":"10.1111\/j.1399-3046.2006.00540.x"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Castells L, Esteban R. Hepatitis B vaccination in liver transplant candidates. Eur J Gastroenterol Hepatol 2001;13:359-361.","DOI":"10.1097\/00042737-200104000-00009"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Dom&iacute;nguez M, B&aacute;rcena R, Garc&iacute;a M, L&oacute;pez-Sanroman A, Nu\u00f1o J. Vaccination against hepatitis B virus in cirrhotic patients on liver transplant waiting list. Liver Transpl 2000;6:440-442.","DOI":"10.1053\/jlts.2000.8313"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Lin CC, Chen CL, Concejero A, Wang CC, Wang SH, Liu YW, Yang CH, Yong CC, Lin TS, Jawan B. Active immunization to prevent de novo hepatitis B virus infection in pediatric live donor liver recipients. Am J Transplant 2007;7:195-200.","DOI":"10.1111\/j.1600-6143.2006.01618.x"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Lee KW, Lee DS, Lee HH, Kim SJ, Joh JW, Seo JM, Choe YH, Lee SK. Prevention of de novo hepatitis B infection from HbcAb-positive donors in living donor liver transplantation. Transplant Proc 2004;36:2311-2312.","DOI":"10.1016\/j.transproceed.2004.08.139"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Stark K, G&uuml;nther M, Sch&ouml;nfeld C, Tullius SG, Bienzle U. Immunisations in solid-organ transplant recipients. Lancet 2002;359:957-965.","DOI":"10.1016\/S0140-6736(02)08028-5"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"B&aacute;rcena R, Fernandez-Braso M, Urman J, L&oacute;pez-San Rom&aacute;n A, del Campo S, Moreno N, Lopez P, Garcia M, Plaza MP, Garcia Plaza A. Response to hepatitis B virus vaccine in patients transplanted for HBV-related liver disease under specific gammaglobulin prophylaxis. Transplant Proc 1999;31:2459-2460.","DOI":"10.1016\/S0041-1345(99)00417-0"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Uemoto S, Sugiyama K, Marusawa H, Inomata Y, Asonuma K, Egawa H, Kiuchi T, Miyake Y, Tanaka K, Chiba T. Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants. Transplantation 1998;65:494-499.","DOI":"10.1097\/00007890-199802270-00007"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Rokuhara A, Tanaka E, Yagi S, Mizokami M, Hashikura Y, Kawasaki S, Kiyosawa K. De novo infection of hepatitis B virus in patients with orthotopic liver transplantation: analysis by determining complete sequence of the genome. J Med Virol 2000;62:471-478.","DOI":"10.1002\/1096-9071(200012)62:4<471::AID-JMV12>3.0.CO;2-X"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50227"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e3181819ad4"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Park JB, Kwon CH, Lee KW, Choi GS, Kim DJ, Seo JM, Kim SJ, Joh JW, Lee SK. Hepatitis B virus vaccine switch program for prevention of de novo hepatitis B virus infection in pediatric patients. Transpl Int 2008;21:346-352.","DOI":"10.1111\/j.1432-2277.2007.00618.x"},{"key":"ref27","unstructured":"Lin CC, Liu YW, Chen CL, Wang CC, Wang SH, Yong CC, Yang CH, Concejero AM, Lin TS, Lin TL. Immunogenicity and long-term effects of active immunization against de novo hepatitis B virus infection in pediatric patients after living donor liver transplantation. Proceedings of the 16th Annual Metting of International Liver Transplantation Society; 2010 June 16-19; Hongkong. Liver Transpl 2010;16 Suppl 1:S197."},{"key":"ref28","unstructured":"Liu YW, Chen CL, Lin CC, Wang CC, Wang SH, Yong CC, Lin TL, Concejero AM, Jawade K, Yap AQ. High level active immunization is a simple practical strategy to prevent de novo hepatitis B virus infection in non-HBV adults after living donor liver transplantation. Proceedings of the 16th Annual Metting of International Liver Transplantation Society; 2010 June 16-19; Hongkong. Liver Transpl 2010;16 Suppl 1:S94."},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990;336:325-329.","DOI":"10.1016\/0140-6736(90)91874-A"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Ghany MG, Ayola B, Villamil FG, Gish RG, Rojter S, Vierling JM, Lok AS. Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. Hepatology 1998;27:213-222.","DOI":"10.1002\/hep.510270133"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20606"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20887"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v21\/i39\/11112.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T20:18:12Z","timestamp":1567282692000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v21\/i39\/11112.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":32,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v21.i39.11112","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}